Sign in

CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company

SELLAS Life Sciences Group, Inc.

Sign in to watch
Ticker
SLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
6462005278
Business address
7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
Former names
GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
  1. 4 Grant or award President and CEO acquired 1,065,000 shares (grant or award)
  2. 4 Grant or award Director acquired 50,000 shares (grant or award)
  3. 4 Grant or award Director acquired 50,000 shares (grant or award)
  4. 4 Grant or award Director acquired 50,000 shares (grant or award)
  5. 4 Grant or award SVP, Chief Development Officer acquired 300,000 shares (grant or award)
  6. 4 Grant or award CFO acquired 300,000 shares (grant or award)
  7. 4 Grant or award Director acquired 50,000 shares (grant or award)
  8. 4 Grant or award Director acquired 50,000 shares (grant or award)
  9. 4 Other disposition SVP, Chief Development Officer disposed of 63,800 shares (other)
  10. 4 Other disposition CFO disposed of 58,592 shares (other)
  11. 4 Other disposition President and CEO disposed of 187,066 shares (other)
  12. 4 Open-market buy Director bought 63,400 shares at $1.59 ($100,806)
  13. 4 Open-market buy Director bought 10,000 shares at $1.48 ($14,800)
  14. 4 Open-market buy Director bought 20,000 shares at $1.69 ($33,800)
  15. 4 Open-market buy Director bought 20,000 shares at $1.80 ($36,000)
  16. 4 Grant or award CFO acquired 194,300 shares (grant or award)
  17. 4 Grant or award President and CEO acquired 500,900 shares (grant or award)
  18. 4 Grant or award Director acquired 12,500 shares (grant or award)
  19. 4 Grant or award Director acquired 12,500 shares (grant or award)
  20. 4 Grant or award Director acquired 12,500 shares (grant or award)

Page 1 of 22 · 436 filings